Blocking Th17 cells to halt autoimmunity in diseases like multiple sclerosis

T-helper cells that produce interleukin-17 (TH17 cells) play a role in autoimmunity: Their development is controlled by retinoic-acid-receptor-related orphan receptors alpha and gamma-T and antagonists of these receptors, Digoxin or SR1001, blocks their development , and reduce cytokine secretion andthe clinical severity of autoimmune disease in mice (experimental encephalomyelitis)
See Nature Papers

 Multiple sclerosis genes, risk factors and KEGG pathways 
Enhanced by Zemanta

No comments: